KATHLEEN BRADFORD: Open Payments
NPI 1881820009 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 46 payments from 15 companies in 2025. Trend: 2023 $1,351 · 2024 $1,428 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $207 |
| Janssen Biotech, Inc. | 5 | $116 |
| Collegium Pharmaceutical, Inc. | 6 | $108 |
| UCB, Inc. | 4 | $103 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $88 |
| Lundbeck LLC | 3 | $80 |
| Amgen Inc. | 3 | $69 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| SCILEX PHARMACEUTICALS INC. | 2 | $38 |
| Sandoz Inc. | 1 | $28 |
Products named: TREMFYA, QULIPTA, XTAMPZA, Bimzelx, RELISTOR, VYEPTI, UBRELVY, OTEZLA.
Industry payments across GA — which companies pay providers there.
